Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/131636
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHorowitz, M.-
dc.contributor.authorRayner, C.K.-
dc.contributor.authorMarathe, C.S.-
dc.contributor.authorWu, T.-
dc.contributor.authorUmapathysivam, M.-
dc.contributor.authorJones, K.L.-
dc.date.issued2021-
dc.identifier.citationDiabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 2021; 23(10):2411-2413-
dc.identifier.issn1462-8902-
dc.identifier.issn1463-1326-
dc.identifier.urihttp://hdl.handle.net/2440/131636-
dc.descriptionLetter to the Editor-
dc.description.abstractAbstract not available.-
dc.description.statementofresponsibilityMichael Horowitz, Christopher K. Rayner, Chinmay S. Marathe, Tongzhi Wu, Mahesh Umapathysivam, Karen L. Jones-
dc.language.isoen-
dc.publisherWiley-
dc.rights© 2021 John Wiley & Sons Ltd-
dc.source.urihttp://dx.doi.org/10.1111/dom.14473-
dc.subjectHumans-
dc.subjectDiabetes Mellitus, Type 2-
dc.subjectGlucose-
dc.subjectGastric Emptying-
dc.subjectPostprandial Period-
dc.subjectLipid Metabolism-
dc.subjectGlucagon-Like Peptides-
dc.titleResponse to Dahl et al: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes-
dc.typeJournal article-
dc.identifier.doi10.1111/dom.14473-
dc.relation.grantNHMRC-
pubs.publication-statusPublished-
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]-
dc.identifier.orcidRayner, C.K. [0000-0002-5527-256X]-
dc.identifier.orcidWu, T. [0000-0003-1656-9210]-
dc.identifier.orcidJones, K.L. [0000-0002-1155-5816]-
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.